Novo Nordisk's pricing strategies during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of rate gouging, pointing out the stark contrast amongst U.S. prices and people in Europe and copyright. Other serps affiliate your advert-click on